| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |